Skip to main content

Heart Failure News (Page 7)

Related terms: CHF

CMP Pharma, Inc. Announces FDA Approval of CaroSpir (spironolactone) Oral Suspension

Farmville, NC. August 7, 2017 – CMP Pharma today announced that the US Food and Drug Administration (FDA) has granted final approval of the company’s New Drug Application (NDA) for CaroSpir (Sp...

FDA Approves Qbrelis (lisinopril) Oral Solution for Pediatric Patients 6 Years of Age and Older

Denver, July 29, 2016 — Silvergate Pharmaceuticals, Inc., leader in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food a...

FDA Approves Entresto (sacubitril/valsartan) for Heart Failure

July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of...

FDA Approves Corlanor (ivabradine) to Treat Heart Failure

April 15, 2015 – The U.S. Food and Drug Administration today approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure. Corlanor is approved for use in certain people...

FDA Medwatch Alert: Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates

ISSUE: Hospira, Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 mg, 20 mL, Single-dose fliptop vial, (NDC 0409-2344-02), Lot 27-352-DK. (NDC and lot...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Left Ventricular Dysfunction, Cardiovascular Conditions and Disorders

Related drug support groups

lisinopril, metoprolol, warfarin, Coumadin, spironolactone, triamcinolone, carvedilol, Metoprolol Succinate ER, diltiazem, view more... Lasix, furosemide, bisoprolol, Entresto, valsartan, Farxiga, Jardiance, ramipril, digoxin, prazosin, Coreg, Diovan, nitroglycerin